Pediatr. praxi. 2025;26(5):337-341

What the post-COVID period has brought in the field of influenza-like ilnesses

MUDr. Pavel Kostiuk, CSc.1, PharmDr. Lucie Kotlářová2, PharmDr. Zdeněk Procházka1
1 Edukafarm, Jesenice u Prahy
2 InPharm Clinic, Jesenice u Prahy

Research and clinical experience increasingly clearly show that significant consequences of SARS-CoV-2 infection include significant long-term dysregulation of the immune system. The pathophysiological mechanisms of this disorder, which is part of the post-COVID syndrome, include, for example, persistent inflammatory activation, functional exhaustion of T lymphocytes, impaired memory of B lymphocytes and antibody responses, the formation of autoantibodies, and reactivation of latent herpes viruses (especially EBV). Immune disorders have also been described in patients with initially mild or home-managed course of COVID-19. A significant consequence of these conditions is reduced anti-infective immunity, including defense against influenza-like illneses (ILI). The aim of this review is to summarize the current knowledge about the mechanism of immune dysregulation in the post-COVID period, typical clinical manifestations, and implications for the prevention and treatment of ILI.

Keywords: influenza-like ilnesses, COVID-19, post-covid syndrome, anti-infectious immunity, immunostimulation.

Published: October 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kostiuk P, Kotlářová L, Procházka Z. What the post-COVID period has brought in the field of influenza-like ilnesses. Pediatr. praxi. 2025;26(5):337-341.
Download citation

References

  1. Spencer JA, Shutt DP, Moser SK, et al. Distinguishing viruses responsible for influenza-like illness. J Theor Biol. 2022; 545:111145. Go to original source...
  2. Davis HE, Assaf GS, McCorkell L, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133-146. Go to original source...
  3. Lage SL, Bricker-Holt K, Rocco JM, et al. Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infection. medRxiv. 2025; 2025.04.16.25325949.
  4. Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187:5500-5529. Go to original source...
  5. Gupta G, Buonsenso D, Wood J, et al. Mechanistic insights into Long COVID: viral persistence, immune dysregulation, and multi-organ dysfunction. Compr Physiol. 2025;15:e70019. Go to original source...
  6. Notarte KI, Carandang THDC, Velasco JV, et al. Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review. Front Immunol. 2024;15:1428645. Go to original source...
  7. Yin K, Peluso MJ, Luo X, et al. Long COVID manifests with T cell dysregulation and exhausted SARS-CoV-2-specific CD8+ T cells. Nat Immunol. 2024;25:218-225. Go to original source...
  8. Cwilichowska-Puslecka N, Makowiecka A, Kalinka M, et al. Understanding the long-term interplay of SARS-CoV-2 and immune recovery. Front Immunol. 2025;16:1517933. Go to original source...
  9. Mandel H, Yoo YJ, Allen AJ, et al. Long COVID incidence proportion in adults and children between 2020 and 2024: an electronic health record-based study from the RECOVER Initiative. Clin Infect Dis. 2025;80:1247-1261. Go to original source...
  10. Ewing AG, Joffe D, Blitshteyn S, et al. Long COVID clinical evaluation, research and impact on society: a global expert consensus. Ann Clin Microbiol Antimicrob. 2025;24:27. Go to original source...
  11. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9:1211. Go to original source...
  12. Vollbracht C, Raithel M, Krick B, et al. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study. J Int Med Res. 2018;46:3640-3655. Go to original source...
  13. Uesato S, Kitagawa Y, Kaijima T, et al. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation. Cancer Lett. 2001;66:143-146. Go to original source...
  14. Cinatl J, Cinatl J, Weber B, et al. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res. 1995;27:405-418. Go to original source...
  15. Leibovitz B, Siegel BV. Ascorbic acid and the immune response. Adv Exp Med Biol. 1981;135:1-25. Go to original source...
  16. Kim Y, Kim H, Bae S, et al. Vitamin C is an essential factor on the anti-viral immune response through the production of interferon-alpha/beta at the initial stage of influenza A virus (H3N2) infection. Immune Netw. 2013;13:70-74. Go to original source...
  17. Li W, Maeda N, Beck MA. Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/- mice. J Nutr. 2006;136:2611-2616. Go to original source...
  18. Cai Y, Li YF, Tang LP, et al. A new mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced pneumonia in restraint-stressed mice. Biomed Res Int. 2015;2015:675149. Go to original source...
  19. Kataoka A, Imai H, Inayoshi S, et al. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psy. 1993;56:1213-1216. Go to original source...
  20. Harakeh S. NF-kappa B-independent suppression of HIV expression by ascorbic acid. AIDS Res Hum Retroviruses. 1997;13:235-239. Go to original source...
  21. Hosakote YM, Jantzi PD, Esham DL, et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2011;183:1550-1560. Go to original source...
  22. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537. Go to original source...
  23. Ahn H, Park JH. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016;20:36. Go to original source...
  24. Fan C, Pacier C, Martirosyan DM. Rose hip (Rosa canina L): A functional food perspective. Funct Foods Health Dis. 2014;4:493-509. Go to original source...
  25. Boženský J, Kopřiva F, Kotlářová L, et al. Vitamin C, antiinfekční imunita a problematika snížených hladin u dětí. Pediatr praxi. 2021;22(2):98-104. Go to original source...
  26. Mousa HAL. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med 2017;22:66-174. Go to original source...
  27. Colombo M, Rigamonti G, Danza ML, et al. Comparative evaluation of Guna-Flu vs vaccine for the prevention of influenza syndrome in paediatrics - A prospective, multicentric randomized, controlled clinical trial. Physiological Regulating Medicine. 2007;2(1):3-10.
  28. Supino C. Prevenzione delle infezioni delle alte vie respiratporie in eta pediatrica con Omeogriphi: studio multi­centrico controllato. La Medicina Biologica. 2002;20(3): 19-23.
  29. Arrighi A. Omeogriphi vs. paracetamolo nel trattamento della sindrome influenzale - studio clinico prosperrico controllato. La Medicina Biologica. 2013;31(4):3-12.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.